Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors

Body composition refers to the proportional content of body fat mass and lean body mass that can lead to a continuum of different phenotypes ranging from cachectic/sarcopenic state to obesity. The heterogenetic phenotypes of body composition can contribute to formation of some cancer types and can s...

Full description

Bibliographic Details
Main Authors: Karam Khaddour, Sandra L. Gomez-Perez, Nikita Jain, Jyoti D. Patel, Yanis Boumber
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
body composition
obesity
sarcopenia
tyrosine kinase inhibitor
immune checkpoint inhibitor
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.576314/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.576314/full

Similar Items